netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Introduction

Welcome to the formulary

Useful Links

 

 
Paediatric Formulary (Evelina Hospital)

MHRA YellowCard

 

Specialist Pharmacy Service Homepage


NHS England coronavirus guidance for clinicians and NHS managers 


SE London Integrated Medicines Optimisation Homepage


Compliance with NICE technology appraisals

OpenPrescribing Homepage

Medicines A to Z Homepage

 

News Feed

Jun 21- MHRA Drug Safety Update: Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years


Jun 21- MHRA Drug Safety Update: Oral retinoid medicines (isotretinoin▼, alitretinoin▼, and acitretin▼): temporary monitoring advice during coronavirus (COVID-19) pandemic


Jun 21- MHRA Drug Safety Update: CDK4/6 inhibitors (abemaciclib▼, palbociclib▼, ribociclib▼): reports of interstitial lung disease and pneumonitis, including severe cases


Jun 21- MHRA Drug Safety Update: Atezolizumab (Tecentriq▼) and other immune-stimulatory anti-cancer drugs: risk of severe cutaneous adverse reactions (SCARs)


Jun 21- MHRA Drug Safety Update: Letters and medicine recalls sent to healthcare professionals in May 2021


 May 21 - MHRA Drug Safety Update: Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products


>>> more news

Welcome to the South East London Joint Medicines Formulary

This formulary is a prescribing list that includes the names of medicines approved by the Joint Formulary Committee (JFC) and Integrated Medicines Optimisation Committee (IMOC) for use across the South East London Integrated Care System:

  • Guy’s and St Thomas’ NHS Foundation Trust (GSTFT)
  • King’s College Hospital NHS Foundation Trust (KCH)
  • Lewisham and Greenwich NHS Trust (LGT)
  • South East London Clinical Commissioning Group (CCG)

Availability in each Trust is indicated within each drug entry. Infrequently used formulary products may need to be ordered if not routinely stocked.

 

This formulary does not contain the information necessary for prescribing, dispensing or administration. It should be used in conjunction with the British National Formulary (BNF), supplemented as necessary from specialist publications and manufacturers’ Summaries of Product Characteristics (SPC), local guidelines and national guidelines. It is intended for use by prescribers who have the necessary training and experience to interpret the information it provides.

Supplementary information is available from local Medicines Information/Formulary services:

  • Guy’s and St Thomas’ NHS Foundation Trust (Medicines Information extensions 83849, 83855, 88750; Formulary extension 83854 - outside line 020 7188 3854)
  • King’s College Hospital NHS Foundation Trust (extension 30355)
  • Lewisham and Greenwich NHS Trust (Medicines Information 020 8836 4900; Formulary 020 8836 4847).

Unlicensed medicines/uses

Unlicensed medicines or uses of licensed products that fall outside the marketing authorisation have been included for use in specific clinical settings, where these have been approved for formulary inclusion. Prescribers must take full responsibility for prescribing such products and comply with the Unlicensed Medicines Policy as approved at individual Trust level.

Disclaimer

Every attempt has been made to ensure that the information in this formulary is correct, but errors may have occurred. Where there is doubt, information should be verified against relevant specialist publications


NetFormulary
   Last updated: 30/07/2021 17:03:31.